Sickle Cell Nephropathy in the Pediatric Population

Area of Science:

• Nephrology
• Pediatrics
• Hematology

Background:

• Sickle cell disease (SCD) patients live longer, increasing the challenge of chronic complications like sickle cell nephropathy (SCN).
• SCN is a significant cause of morbidity and mortality, often presenting with few symptoms and requiring close monitoring.
• This review focuses on the epidemiology, natural history, and treatment of SCN, particularly in children.

Purpose of the Study:

• To explore the epidemiology and natural history of sickle cell nephropathy (SCN) in pediatric patients.
• To review current and novel treatment options for SCN in children.
• To highlight the challenges in diagnosing and managing SCN in the pediatric population.

Main Methods:

• Review of existing literature on sickle cell nephropathy (SCN) in pediatric populations.
• Analysis of epidemiological data and natural history studies.
• Evaluation of treatment strategies, including ACE inhibitors and hydroxyurea.

Main Results:

• SCN begins in childhood, with structural changes detectable in infancy.
• Significant albuminuria is a key factor in SCN progression, but early biomarkers are needed.
• Challenges in pediatric SCN management include poor GFR correlation and lack of longitudinal data.

Conclusions:

• SCN is an indolent childhood complication of SCD that can lead to advanced kidney disease.
• Early detection and intervention are critical, necessitating research into novel biomarkers and treatments.
• Further longitudinal studies are required to understand and manage SCN in pediatric patients effectively.